First Horizon Corporation’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5M Buy
73,329
+2,560
+4% +$551K 0.71% 43
2026
Q1
$15.4M Buy
70,769
+1,764
+3% +$391K 0.64% 48
2025
Q4
$15.8M Sell
69,005
-299
-0.4% -$68.1K 0.7% 45
2025
Q3
$16M Buy
+69,304
New +$14.1M 0.75% 38
2021
Q2
$2.48M Buy
21,979
+334
+2% +$37.6K 0.22% 104
2021
Q1
$2.34M Buy
21,645
+1,030
+5% +$110K 0.22% 109
2020
Q4
$2.21M Buy
20,615
+1,053
+5% +$101K 0.22% 108
2020
Q3
$1.71M Buy
+19,562
New +$1.84M 0.18% 107
2013
Q2
$608K Buy
+14,712
New +$643K 0.17% 130

Other funds holding ABBV

First Horizon Corporation's ABBV Position: Q2 2026 in Review

First Horizon Corporation increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $551K and bringing the position to 73,329 shares worth $18.5M. The position accounts for 0.71% of the portfolio, ranked #43.

First Horizon Corporation first reported a position in ABBV in Q2 2013 and has held it in 9 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Horizon Corporation held 73,329 shares of AbbVie worth $18.5M as of Q2 2026.
  • First Horizon Corporation bought 2,560 AbbVie shares in Q2 2026, an estimated $551K.
  • AbbVie made up 0.71% of First Horizon Corporation's portfolio in Q2 2026, its #43 holding.
  • First Horizon Corporation first reported a position in AbbVie in Q2 2013 and has held it in 9 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.